» Articles » PMID: 32981703

Mortality Due to Hospital-acquired Infection After Cardiac Surgery

Overview
Date 2020 Sep 28
PMID 32981703
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hospital-acquired infections have been associated with significant morbidity and mortality in critically ill surgical patients. However, little is known about mortality due to hospital-acquired infections in cardiac surgery.

Methods: We conducted a retrospective analysis of prospectively collected data from the cardiac surgery unit of a university hospital. All patients who underwent cardiac surgery over a 7-year period were included. Patients with hospital-acquired infections were matched 1:1 with patients with nonhospital-acquired infections based on risk factors for hospital-acquired infections and death after cardiac surgery using propensity score matching. We performed a competitive risk analysis to study the mortality fraction due to hospital-acquired infections.

Results: Of 8853 patients who underwent cardiac surgery, 370 (4.2%) developed 500 postoperative infections (incidence density rate 4.2 hospital-acquired infections per 1000 patient-days). Crude hospital mortality was significantly higher in patients with hospital-acquired infections than in matched patients who did not develop hospital-acquired infections, 15.4% and 5.7%, respectively (P < .001). The in-hospital mortality fraction due to hospital-acquired infections in our cohort was 17.1% (12.3%-22.8%). Pseudomonas aeruginosa infection (hazard ratio, 2.09; 95% confidence interval, 1.23-3.49; P = .005), bloodstream infection (hazard ratio, 2.08; 95% confidence interval, 1.19-3.63; P = .010), and pneumonia (hazard ratio, 1.68; 95% confidence interval, 1.02-2.77; P = .04) were each independently associated with increased hospital mortality.

Conclusions: Although hospital-acquired infections are relatively uncommon after cardiac surgery (4.2%), these infections have a major impact on postoperative mortality (attributable mortality fraction, 17.1%).

Citing Articles

Which antimicrobial treatment for patients with bloodstream infection during ECMO support?.

Massart N, Ortuno S, Vidal C, Henri S, Roze H, Bougle A Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 39920427 DOI: 10.1007/s10096-025-05059-y.


Evaluation of systemic inflammatory response following transcatheter aortic valve replacement: a pathway to rational antibiotic use.

Guthoff H, Lohner V, Mons U, Gotz J, Wienemann H, Wrobel J Infection. 2025; .

PMID: 39918726 DOI: 10.1007/s15010-025-02485-0.


The Extra Length of Stay, Costs, and Mortality Associated With Healthcare-Associated Infections: A Case-Control Study.

Moradi S, Najafpour Z, Cheraghian B, Keliddar I, Mombeyni R Health Sci Rep. 2024; 7(11):e70168.

PMID: 39512247 PMC: 11540804. DOI: 10.1002/hsr2.70168.


Post-operative infections after cardiothoracic surgery and vascular procedures: a bibliometric and visual analysis of the 100 most-cited articles in the past 2 decades.

Ali M, Akram B, Bokhari M, Ahmed A, Anwar A, Talha M GMS Hyg Infect Control. 2024; 19:Doc29.

PMID: 38883404 PMC: 11177225. DOI: 10.3205/dgkh000484.


A nomogram predicting pneumonia after cardiac surgery: a retrospective modeling study.

Wang K, Zhang H, Fan F, Pan J, Pan T, Wang D J Cardiothorac Surg. 2024; 19(1):309.

PMID: 38822375 PMC: 11140971. DOI: 10.1186/s13019-024-02797-6.